Radiomics-Based AI Model for Predicting Para-Aortic Lymph Node Metastasis in Gastric Cancer Patients
Launched by QUN ZHAO · Apr 21, 2025
Trial Information
Current as of July 25, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Adults aged 18-80 years.
- • 2. Histologically confirmed gastric adenocarcinoma.
- • 3. Planned to undergo radical gastrectomy with or without para-aortic lymph node dissection.
- • 4. Preoperative contrast-enhanced abdominal CT scan available within 3 weeks before surgery.
- • 5. No evidence of distant metastasis on imaging.
- • 6. ECOG performance status 0-2.
- • 7. Provided written informed consent.
- Exclusion Criteria:
- • 1. History of other malignant tumors within the past 5 years.
- • 2. Received neoadjuvant chemotherapy or radiotherapy prior to CT imaging.
- • 3. Poor-quality or incomplete CT images not suitable for radiomics analysis.
- • 4. Severe comorbidities that may affect prognosis or surgical decision-making.
- • 5. Pregnancy or breastfeeding.
- • 6. Inability to provide informed consent or comply with study procedures.
About Qun Zhao
Qun Zhao is a dedicated clinical trial sponsor with a robust commitment to advancing medical research and improving patient outcomes. With expertise in designing and implementing innovative clinical studies, Qun Zhao focuses on developing new therapies and interventions across various therapeutic areas. The organization prioritizes ethical standards, rigorous scientific methodologies, and collaboration with healthcare professionals and regulatory bodies to ensure the integrity and success of its trials. Through a patient-centered approach, Qun Zhao aims to contribute significantly to the evolving landscape of healthcare and drive transformative solutions for unmet medical needs.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Shijiazhuang, None Selected, China
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported